Contact
searchSearch
HMP Global
Login

Advertisement

Advertisement

ADVERTISEMENT

Access Support Resource Center

Featured

News
US Cancer Centers Still Struggling with Chemotherapy Shortages, NCCN’s Recent Survey Reveals
11/04/2023

Brandon Twyford

Brandon Twyford
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent...
11/04/2023
Journal of Clinical Pathways
News
Tracking Cost of Care Discussions Between Physicians and Patients with NSCLC and Melanoma
10/30/2023

Grace Taylor

Grace Taylor
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and...
10/30/2023
Journal of Clinical Pathways
News
Do Medically Integrated Pharmacies Reduce the Abandonment Rate of Oral Anticancer Medications?
10/30/2023

Emry Lloyd

Emry Lloyd
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured...
10/30/2023
Journal of Clinical Pathways
News
The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs
10/28/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and...
10/28/2023
Journal of Clinical Pathways
News
The Impact of Dosing Approaches for Lenalidomide on Total Cost of Care
10/27/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US...
10/27/2023
Journal of Clinical Pathways
News
Access to Pediatric Palliative Care Assessed in Resource-Constrained Communities
10/27/2023

Emry Lloyd

Emry Lloyd
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues...
10/27/2023
Journal of Clinical Pathways
News
Rollback of Prescription Delivery Flexibilities Poses Challenges for At-Risk Cancer Patients
10/27/2023

Brandon Twyford

Brandon Twyford
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023...
10/27/2023
Journal of Clinical Pathways
News
The Influence of End-of-Life Care Costs on Episodic Value-Based Care Models
10/26/2023

Emry Lloyd

Emry Lloyd
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma,...
10/26/2023
Journal of Clinical Pathways
News
Virtual Consult Pilot Successfully Implemented in Integrated Health System
10/26/2023

Brandon Twyford

Brandon Twyford
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult...
10/26/2023
Journal of Clinical Pathways
News
Outpatient Chemotherapy Safety Improved Through a Multidisciplinary Quality Improvement Program
10/26/2023

Brandon Twyford

Brandon Twyford
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates...
10/26/2023
Journal of Clinical Pathways
News
Shift to Oral Anti-Cancer Drugs Impacting OCM: Study Shows Rise in Part D Drug Expenses
10/26/2023

Brandon Twyford

Brandon Twyford
Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.
Researchers examined the impact of the shift toward oral anti-cancer drugs and the consequent rise in costs within the Oncology Care Model. The abstract was presented at the 2023 ASCO Quality Care Symposium in Boston, Massachusetts.
Researchers examined the impact...
10/26/2023
Journal of Clinical Pathways

News

News
US Cancer Centers Still Struggling with Chemotherapy Shortages, NCCN’s Recent Survey Reveals
11/04/2023

Brandon Twyford

Brandon Twyford
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent survey of cancer centers reveals a persisting shortage of chemotherapy drugs within the US, with 72% of centers reporting a shortage of carboplatin and 59% facing challenges with obtaining cisplatin.
Results from NCCN's recent...
11/04/2023
Journal of Clinical Pathways
News
Tracking Cost of Care Discussions Between Physicians and Patients with NSCLC and Melanoma
10/30/2023

Grace Taylor

Grace Taylor
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and Michael T. Halpern, MD, PhD, MPH, examine the documentation of cost of care discussions between physicians and patients with non–small cell lung cancer and melanoma.
Robin Yabroff, PhD, MBA, and...
10/30/2023
Journal of Clinical Pathways
News
Do Medically Integrated Pharmacies Reduce the Abandonment Rate of Oral Anticancer Medications?
10/30/2023

Emry Lloyd

Emry Lloyd
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured the impact of medically integrated pharmacies on prescription medication abandonment rates.
Dr Doshi and colleagues measured...
10/30/2023
Journal of Clinical Pathways
News
The Impact of Lower Cost Alternatives or Biosimilars on The Cost of Key Cancer Drugs
10/28/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and colleagues examined the impact of lower cost alternative drugs or biosimilars on the cost of key cancer drugs.
Puneeth Indurlal, MD, MS, and...
10/28/2023
Journal of Clinical Pathways
News
The Impact of Dosing Approaches for Lenalidomide on Total Cost of Care
10/27/2023

Grace Taylor

Grace Taylor
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US Oncology Network, McKesson, The Woodlands, Texas, and colleagues investigated the impact of different dosing approaches of lenalidomide on the total cost of care for patients in The US Oncology Network.
Puneeth Indurlal, MD, MS, The US...
10/27/2023
Journal of Clinical Pathways
News
Access to Pediatric Palliative Care Assessed in Resource-Constrained Communities
10/27/2023

Emry Lloyd

Emry Lloyd
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues assessed the care capacity and improvement strategies of pediatric institutions that care for children with cancer.
Dr Houston and colleagues...
10/27/2023
Journal of Clinical Pathways
News
Rollback of Prescription Delivery Flexibilities Poses Challenges for At-Risk Cancer Patients
10/27/2023

Brandon Twyford

Brandon Twyford
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023 ASCO Quality Care Symposium revealed unequal impacts on patients from recent policy changes preventing home delivery of prescription oncology medication.
Research presented at the 2023...
10/27/2023
Journal of Clinical Pathways
News
The Influence of End-of-Life Care Costs on Episodic Value-Based Care Models
10/26/2023

Emry Lloyd

Emry Lloyd
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma, MS, and colleagues examine the impact of end-of-life costs on patients and caregivers, and how it influences value-based care models for physicians.
In this study, Gunjan Sharma,...
10/26/2023
Journal of Clinical Pathways
News
Virtual Consult Pilot Successfully Implemented in Integrated Health System
10/26/2023

Brandon Twyford

Brandon Twyford
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult pilot launched by Kaiser Permanente saw success in bridging the gap between oncologists and cancer subspecialists within the organization.
An innovative virtual consult...
10/26/2023
Journal of Clinical Pathways
News
Outpatient Chemotherapy Safety Improved Through a Multidisciplinary Quality Improvement Program
10/26/2023

Brandon Twyford

Brandon Twyford
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates from ambulatory chemotherapy pumps that caused disruptions in dose deliveries were analyzed and a quality improvement program was initiated to address concerns over safe delivery of chemotherapy to patients.
In this study, high alarm rates...
10/26/2023
Journal of Clinical Pathways
News
Patients With Breast Cancer Experience High Economic Burden and Lower HRQoL: Literature Review
05/15/2024
Grace Taylor, MS, MA
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review summarizes the economic and health-related quality of life (HRQoL) outcomes experienced by patients with early-stage hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative...
A systematic literature review...
05/15/2024
Journal of Clinical Pathways
News
The Economic Impact of Artificial Intelligence Usage in Screening Mammography
05/10/2024
Grace Taylor, MS, MA
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the potential economic impact of artificial intelligence (AI) implementation on screening mammography from the perspective of treatment facilities and payers.
Researchers evaluated the...
05/10/2024
Journal of Clinical Pathways
News
MorphoSys’ Myelofibrosis Drug Results Cast Doubt on Novartis Acquisition Deal
05/08/2024
Grace Taylor, MS, MA
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion acquisition deal with Novartis may be in jeopardy due to reports regarding safety problems with its investigational myelofibrosis drug pelabresib.
MorphoSys’ $2.9 billion...
05/08/2024
Journal of Clinical Pathways
News
Dietary Recommendations for Patients With Myelofibrosis
04/22/2024

Grace Taylor

Grace Taylor
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help patients with myelofibrosis have more energy, better immune function, and more.
A balanced diet can help...
04/22/2024
Journal of Clinical Pathways
News
Study Estimates the Total Lifetime Cost of Treating Patients With CLL in the US
04/12/2024

Grace Taylor

Grace Taylor
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan, MD, and colleagues estimated the total lifetime cost of treating patients with chronic lymphocytic leukemia in the US.
A recent study by Farrukh Awan,...
04/12/2024
Journal of Clinical Pathways
News
Exploring Novel Therapies in Oncology: Lessons From the Oncology Care Model
04/11/2024

Brandon Twyford

Brandon Twyford
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024 NCCN Annual Conference gives insight into care quality, cost dynamics, and the evolving landscape of oncologic innovation.
A study presented at the 2024...
04/11/2024
Journal of Clinical Pathways
News
Impact of Care Delays on Health Care Resource Utilization in Patients With Early-Stage Lung Cancer
04/11/2024

Brandon Twyford

Brandon Twyford
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on the real-world ramifications of delayed surgical intervention in early-stage non–small cell lung cancer, highlighting the complex relationship between timing of surgery, patient outcomes, and health care...
Researchers conducted a study on...
04/11/2024
Journal of Clinical Pathways
AI
News
The Potential for AI in Oncology
04/11/2024
Grace Taylor, MS, MA
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay Doddamani, MD, MBA, provide an overview of where artificial intelligence technology stands today and how it comes into play within the oncology space.
Jim Chen, MD, and Sanjay...
04/11/2024
Journal of Clinical Pathways
News
Disease Progression for Patients With Low-Risk Myelofibrosis Participating in the MOST Study
03/26/2024

Grace Taylor

Grace Taylor
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined disease progression for patients with low-risk myelofibrosis participating in the prospective observational MOST study.
A group of researchers examined...
03/26/2024
Journal of Clinical Pathways
News
Rusfertide Treatment Strengthens Response and Decreases Erythrocytosis Among Patients With Polycythemia Vera
03/22/2024

Jordan Kadish

Jordan Kadish
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the phase 2 REVIVE trial, rusfertide treatment demonstrated improved responses and decreased erythrocytosis among patients with polycythemia vera.
According to findings from the...
03/22/2024
Oncology

Interviews

Lee Fleisher, MD
Interview
CMS National Quality Strategy Focuses on Quality, Safety, Affordability Standards in Oncology Care
11/10/2022
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the...
11/10/2022
Journal of Clinical Pathways
Overcoming Resource, Reimbursement Barriers to Comprehensive Cancer Care Delivery
Interview
Overcoming Resource, Reimbursement Barriers to Comprehensive Cancer Care Delivery
07/10/2020
At the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program(May 29-31, 2020), the Association of Community Cancer Centers (ACCC) presented the preliminary results of a member survey on...
At the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program(May 29-31, 2020), the Association of Community Cancer Centers (ACCC) presented the preliminary results of a member survey on...
At the...
07/10/2020
Journal of Clinical Pathways
Kerry Rogers, MD
Interview
Venetoclax Plus Ibrutinib Combination Therapy for Treating Patients With CLL With Resistance Mutations
04/19/2024

Featuring Kerry Rogers, MD, The Ohio State University

Featuring Kerry Rogers, MD, The Ohio ...
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State University, discusses results from her study on how Bruton tyrosine kinase (BTK) inhibitors ibrutinib and venetoclax could help eliminate molecular resistance in patients with CLL who have resistance mutations.
Kerry Rogers, MD, The Ohio State...
04/19/2024
Journal of Clinical Pathways
Interview
Chronic Lymphocytic Leukemia Pathways in Practice at Rocky Mountain Cancer Centers
03/27/2024
John Burke, MD, discusses the current treatment landscape for chronic lymphocytic leukemia and describes how his center ensures a comprehensive approach to patient care.
John Burke, MD, discusses the current treatment landscape for chronic lymphocytic leukemia and describes how his center ensures a comprehensive approach to patient care.
John Burke, MD, discusses the...
03/27/2024
Journal of Clinical Pathways
Bradley Corr, MD
Conference Coverage
Rucaparib Maintenance Therapy Improved Progression-Free Survival Among Patients With Recurrent or Metastatic Endometrial Cancer
03/21/2024

Featuring Bradley Corr, MD

Featuring Bradley Corr, MD
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting on Women’s Cancers, Bradley Corr, MD, discusses the results from a study evaluating rucaparib maintenance therapy for patients with metastatic or recurrent endometrial cancer.
At the 2024 SGO Annual Meeting...
03/21/2024
Oncology
Jing-Zhou Hou, MD, PhD
Videos
Clinical and Demographic Factors Impacting Treatment Selection for Patients With CLL in Community Oncology Settings
03/21/2024

Featuring Jing-Zhou Hou, MD, PhD

Featuring Jing-Zhou Hou, MD, PhD ...
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD, discusses how the standard of care for CLL has evolved among community oncologists since 2020 and how clinical and demographic factors impact treatment selection.
Jing-Zhou Hou, MD, PhD,...
03/21/2024
Journal of Clinical Pathways
Michiel van der Heijden, MD 
Conference Coverage
Enfortumab Vedotin Plus Pembrolizumab Potential New Standard of Care for Advanced Urothelial Carcinoma in the First-Line Setting
01/26/2024

Featuring Michiel van der Heijden, MD 

Featuring Michiel van der Heijden, MD...
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD, discusses the subgroup analyses of the phase 3 EV-302 study, evaluating enfortumab vedotin plus pembrolizumab among patients with locally advanced or metastatic urothelial carcinoma in the first-line setting.
Michiel van der Heijden, MD,...
01/26/2024
Oncology
James Hamrick, MD, MPH
Interview
Improving Patient Care Through AI Clinical Decision Support Tools
03/21/2023
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH, discusses the ways in which incorporating AI into cancer care can improve the timeliness of care for patients, nudge providers to use novel therapies in practice, and reduce inequities in health care.
James Hamrick, MD, MPH,...
03/21/2023
Journal of Clinical Pathways
Rebecca Maniago, PharmdD, BCOP
Interview
The Value of AI-Enabled Clinical Decision Support Tools in Clinical Pathways
03/20/2023
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP, discusses the impact that AI-enabled clinical decision support will have on clinical pathways, as well as the ways in which technology is playing a large role in the current landscape of oncology care.
Rebecca Maniago, PharmD, BCOP,...
03/20/2023
Journal of Clinical Pathways
HER2-Low Breast Cancer
Anne Hubbard, MBA
Interview
Utilizing Episodic Payments to Improve Access and Quality in Cancer Care
11/15/2022
Anne Hubbard, MBA, Director of Health Policy, American Society for Radiation Oncology, discusses the Radiation Oncology Model, which may pave a path for use of an episode-based payment concept in the broader realm of cancer care.
Anne Hubbard, MBA, Director of Health Policy, American Society for Radiation Oncology, discusses the Radiation Oncology Model, which may pave a path for use of an episode-based payment concept in the broader realm of cancer care.
Anne Hubbard, MBA, Director of...
11/15/2022
Journal of Clinical Pathways
Lee Fleisher, MD
Interview
CMS National Quality Strategy Focuses on Quality, Safety, Affordability Standards in Oncology Care
11/10/2022
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the...
11/10/2022
Journal of Clinical Pathways

Blog

Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023

Jacqlyn Riposo, MBA; Tom Valuck, MD, JD

Jacqlyn Riposo, MBA; Tom Valuck, MD, ...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023

David Blaisdell; Sarena Ho, MSPH; Tom Valuck, MD, JD

David Blaisdell; Sarena Ho, MSPH; Tom...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Editor in chief Winston Wong, PharmD.
Editor Insights
Looking at 2023 Key Trends and Insights to Navigate the Future of Value-Based Care
02/13/2024

Winston Wong, PharmD

Winston Wong, PharmD
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature articles in the Journal of Clinical Pathways offered valuable insights into the most important and compelling topics in oncology and other disease areas. This blog collects the top 5 most-read articles of the year.
Throughout 2023, feature...
02/13/2024
Journal of Clinical Pathways
Kendall Logan, MPH.
Quality Outlook
A Tale of Two States: Examining the Best and Worst Performing States for HPV Vaccination
02/12/2024

Kendall Logan, MPH; Anne DiSalvo, MPH, MBA; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Kendall Logan, MPH; Anne DiSalvo, MPH...
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a three-part series exploring the disparities related to human papilloma virus (HPV) vaccination rates in the US.
This blog post is the last in a...
02/12/2024
Journal of Clinical Pathways
Theresa Schmidt headshot.
Quality Outlook
2024 Quality Outlook Revealed: Insights from 2023 Fall Conferences
02/02/2024

Theresa Schmidt, MA; Danny Bellet, MBA; Donna Dugan, PhD, MS; Erik Muther; David Sloan, PhD; Tom Valuck, MD, JD

Theresa Schmidt, MA; Danny Bellet, MB...
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the Real Chemistry Market Access team attended key quality-related events to understand trends and learn from other quality and value experts.
This past fall, leaders from the...
02/02/2024
Journal of Clinical Pathways
Anne Disalvo headshot
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Racial and Ethnic Disparities in HPV Vaccination
11/10/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, the racial and ethnic disparities in HPV vaccination are explored.
This is the second part of a...
11/10/2023
Journal of Clinical Pathways
Anne DiSalvo.
Quality Outlook
Saving Lives from Preventable Cancer: Solutions for Geographic Disparities in HPV Vaccination
10/03/2023

Anne DiSalvo, MPH, MBA; Kendall Logan, MPH; Erik Muther; Blog Editor: Tom Valuck, MD, JD

Anne DiSalvo, MPH, MBA; Kendall Logan...
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part blog series that explores issues related to HPV vaccination rates in the US. In this blog, vaccination disparities are explored among the highest and lowest performing states.
This is the first of a 3-part...
10/03/2023
Journal of Clinical Pathways
David Blaisdell, BA, Real Chemistry.
Quality Outlook
Enhancing Value-Based Oncology Care: What Has CMMI Learned From the OCM?
09/22/2023

David Blaisdell; Blog Editor: Tom Valuck, MD, JD

David Blaisdell; Blog Editor: Tom Val...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about lessons from the Oncology Care Model (OCM) that the Center for Medicare and Medicaid Innovation (CMMI) could apply to the Enhancing Oncology Model (EOM). Subsequently, CMMI recently released an evaluation report for...
We previously wrote about...
09/22/2023
Journal of Clinical Pathways
Jacqlyn Riposo
Quality Outlook
Focus on Outcomes: Quality Measurement Recommendations for CMS’ Medicaid Cell and Gene Therapy Access Model
06/08/2023

Jacqlyn Riposo, MBA; Tom Valuck, MD, JD

Jacqlyn Riposo, MBA; Tom Valuck, MD, ...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers for Medicare and Medicaid Services new cell and Gene Therapy Access Model proposal and recommends different ways the Center for Medicare and Medicaid Innovation can apply quality measurement to cell and gene...
This blog discusses the Centers...
06/08/2023
Journal of Clinical Pathways
Winston Wong
Editor Insights
A Look Back at Clinical Pathways in 2022
02/21/2023
Winston Wong, PharmD, Editor-in-Chief
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal of Clinical Pathway's top 5 articles of 2022.
This blog summarizes the Journal...
02/21/2023
Journal of Clinical Pathways
Sarena Ho, MSPH
Quality Outlook
Quality Measures for Medicare’s Enhancing Oncology Model (EOM): New and Improved or More of the Same?
01/26/2023

David Blaisdell; Sarena Ho, MSPH; Tom Valuck, MD, JD

David Blaisdell; Sarena Ho, MSPH; Tom...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center for Medicare & Medicaid Service’s efforts to advance cancer quality through its new Enhancing Oncology Model (EOM) and presents recommendations for strengthening the EOM measure set and aligning measures across...
This blog discusses the Center...
01/26/2023
Journal of Clinical Pathways
Nina Regenold, MSc
Quality Outlook
The Oncology-Oral Health Value Bridge: Put Your Money Where Your Mouth Is
08/18/2022

Nina Regenold, MSc; Kaitlyn Esselman, MHS; David Blaisdell; Eva Lenoir, MPH; and Tom Valuck, MD, JD

Nina Regenold, MSc; Kaitlyn Esselman,...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and colleagues highlight the need for payers and providers to include oral health in the development of value-based models in oncology care, arguing that doing so could lead to improved patient outcomes and lower costs of...
Nina Regenold, MSc, and...
08/18/2022
Journal of Clinical Pathways

Videos

Video preview image.
Videos
St. Elizabeth’s Innovative Cancer Screening Outreach Model
09/22/2023

Featuring Michael Gieske, MD, and Jamie Ries, RN, BSN

Featuring Michael Gieske, MD, and Jam...
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie Ries, RN, BSN, speak about the development of a care delivery model that demonstrates sustainable outreach for cancer screening, with a specific focus on at-risk and underserved patient populations.
Michael Gieske, MD, and Jamie...
09/22/2023
Journal of Clinical Pathways
Puneeth Indurlal, MD
Videos
Impact of Dose Rounding Bevacizumab and its Biosimilars on Total Cost of Care for OCM Participants
07/26/2023

Featuring Puneeth Indurlal, MD

Featuring Puneeth Indurlal, MD ...
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses the impact of dose rounding that targets bevacizumab and its biosimilars on the total cost of care and drug waste expenditures for Oncology Care Model participants in the US Oncology Network.
Puneeth Indurlal, MD, discusses...
07/26/2023
Journal of Clinical Pathways
Monica Schmidt, PhD.
Videos
The Impact of Elsevier ClinicalPath Oncology Treatment Pathways on Survival and Cost of Care
07/24/2023

Featuring Monica Schmidt, PhD

Featuring Monica Schmidt, PhD
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal of Clinical Pathways, Monica Schmidt, PhD, MPH, discusses her study on the impact of using Elsevier’s ClinicalPath oncology pathways on short-term survival and cost of care from the patient and health system...
In an interview with the Journal...
07/24/2023
Journal of Clinical Pathways
Aaron P. Mitchell, MD, MPH
Videos
Study Examines the Association Between Oncologists’ Receipt of Pharmaceutical Industry Payments and Use of Nonrecommended/Low-Value Treatments
07/20/2023

Featuring Aaron P. Mitchell, MD

Featuring Aaron P. Mitchell, MD ...
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH, discusses his research on the association of pharmaceutical industry payments to oncologists and their increased use of nonrecommended and/or low-value treatment methods.
Aaron P. Mitchell, MD, MPH,...
07/20/2023
Journal of Clinical Pathways
Patricia Santos, MD
Videos
Health Care Access and Affordability for Adult Immigrant Cancer Survivors
06/26/2023

Featuring Patricia Santos, MD

Featuring Patricia Santos, MD
Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...
Patricia Santos, MD, Memorial Sloan Kettering Cancer Center, spoke with the Journal of Clinical Pathways at the ASCO 2023 Annual Meeting about her research on the coverage and affordability of health care access for adult immigrant cancer...
Patricia Santos, MD, Memorial...
06/26/2023
Journal of Clinical Pathways
Lalan Wilfong, MD.
Conference Coverage
Benefits and Challenges of the Enhancing Oncology Model
06/13/2023
At the ASCO 2023 Annual Meeting, Lalan Wilfong, MD, provided an overview of the Enhancing Oncology Model and how it differs from and improves upon the Oncology Care Model.
At the ASCO 2023 Annual Meeting, Lalan Wilfong, MD, provided an overview of the Enhancing Oncology Model and how it differs from and improves upon the Oncology Care Model.
At the ASCO 2023 Annual Meeting,...
06/13/2023
Journal of Clinical Pathways
Dr Daniel Virnich, President, the Oncology Institute.
Videos
A Value-based Framework for Drug Cost Support and Funding Programs
05/11/2023
Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.
Dr Daniel Virnich, President, The Oncology Institute, discusses his presentation on drug cost support and funding programs for patients with cancer from Oncology at Total Health 2022.
Dr Daniel Virnich, President,...
05/11/2023
Journal of Clinical Pathways
Adria Warren, Partner at Foley & Lardner LLP
Videos
New Developments in the 340B Drug Pricing Program
04/03/2023
Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...
Adria Warren, health care transactional partner at Foley & Lardner LLP, spoke with the Journal of Clinical Pathways about new developments in the 340B drug pricing program and provided updates on recent court rulings and cases in process that...
Adria Warren, health care...
04/03/2023
Journal of Clinical Pathways
Lee Fleisher, MD
Videos
Making Clinical Pathways Unique to the Patient Journey
11/14/2022
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses balancing the need for uniform quality care for all patients with finding the proper pathways for individual patients.
Lee Fleisher, MD, discusses...
11/14/2022
Journal of Clinical Pathways
Lee Fleisher, MD
Interview
CMS National Quality Strategy Focuses on Quality, Safety, Affordability Standards in Oncology Care
11/10/2022
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the foundation and goals of the Centers for Medicare and Medicaid Services’ National Quality Strategy, highlighting key components such as quality, safety, and affordability, and emphasizing alignment between all of...
Lee Fleisher, MD, outlines the...
11/10/2022
Journal of Clinical Pathways
Lalan Wilfong, MD
Videos
Balancing the Benefits and Risks of Value-Based Care Arrangements
05/16/2024
Lalan Wilfong, MD
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his key takeaways from the Community Oncology Conference session on defining value-based care in oncology.
Lalan Wilfong, MD, discusses his...
05/16/2024
Journal of Clinical Pathways
BDHC thumbnail
Breaking Down Health Care
The Bear: Why Does Health Care Cost So Much? (Part 1)
05/06/2024

Featuring Michael Kolodziej, MD, and John Hennessy, MBA

Featuring Michael Kolodziej, MD, and ...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part Breaking Down Health Care conversation, John Hennessy, MBA, and Michael Kolodziej, MD, dig into two of the main stakeholders in health care costs: hospitals and health insurance companies. They discuss how these...
In part one of this two-part...
05/06/2024
Cancer Care Business Exchange
Julia Morton
Videos
The Impact of Technology at the Point of Care in Community Practice
05/01/2024
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice president and general manager at Flatiron Health, talks about how recent developments in technology have impacted point-of-care solutions in community oncology.
Julia Morton, senior vice...
05/01/2024
Journal of Clinical Pathways
JCP Flatiron Roundtable 1 Thumbnail
Videos
Oncology Care Pathways: Perspectives on Strategies and Best Practices
05/01/2024

Featuring Gordon Kuntz; Jeremy Drainville; James Hamrick, MD; Larry Shulman, MD; Bryan Loy, MD

Featuring Gordon Kuntz; Jeremy Drainv...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants discuss how to develop and implement clinical pathways at cancer centers. This includes integrating both the latest clinical evidence and payer contract requirements to develop the most efficient clinical...
In this roundtable, participants...
05/01/2024
Journal of Clinical Pathways
Michael Serzan, MD
Videos
Recent Advancements in the Treatment of Renal Cell Carcinoma
04/24/2024

Featuring Michael Serzan, MD, Dana-Farber Cancer Institute

Featuring Michael Serzan, MD, Dana-Fa...
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights some of the latest advancements in the treatment of renal cell carcinoma.
Michael Serzan, MD, highlights...
04/24/2024
Journal of Clinical Pathways
Rose Gerber, MS
Videos
Becoming a Patient Advocate: Tips for Getting Started
04/12/2024

Featuring Rose Gerber, MS

Featuring Rose Gerber, MS
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer survivor Rose Gerber shares her experience in cancer patient advocacy and offers tips for those who wish to become advocates.
Patient advocate and cancer...
04/12/2024
Journal of Clinical Pathways
John Allan, MD, Weill Cornell Medicine
Conference Coverage
Comparing BTK Inhibitors for Frontline Chronic Lymphocytic Leukemia Treatment
04/10/2024

Featuring John Allan, MD

Featuring John Allan, MD
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use of different BTK inhibitors for the treatment of CLL in a frontline setting and discusses whether there is an optimal drug regimen to use among patients with CLL.
John Allan, MD, compares the use...
04/10/2024
Lymphoma, Leukemia & Myeloma Network
Erin Fox, PharmD
Videos
How Health Care Stakeholders in Oncology Can Prepare for and Manage Drug Shortages
04/08/2024

Featuring Erin Fox, PharmD

Featuring Erin Fox, PharmD
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps health care stakeholders can take to mitigate the impact of drug shortages on cancer care.
Erin Fox, PharmD, shares steps...
04/08/2024
Journal of Clinical Pathways
Robert Stillman, MA, RN
Videos
Best Practices in Care Team Communication Technology: Updates From NCCN 2024
04/06/2024

Featuring Robert Stillman, MA, RN

Featuring Robert Stillman, MA, RN ...
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN, describes some of the latest innovations in health care communications technology and how providers can use these tools to improve their practices and provide value-based care.
Robert Stillman, MA, RN,...
04/06/2024
Journal of Clinical Pathways
Anna Halpern, MD
Videos
An Overview of the Benefits and Challenges of Providing Outpatient Oncology Care
04/06/2024

Featuring Anna Halpern, MD

Featuring Anna Halpern, MD
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her National Comprehensive Cancer Network annual conference session on how to balance inpatient and outpatient oncology care.
Anna Halpern, MD, discusses her...
04/06/2024
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

JCP March/April 2024

Current Issue

April 2024
Volume 10
Issue 2
Current Issue
Issue Archive

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Special Reports

JCP Special Report
Recommendations for Creating an Oncology Clinical Pathways Framework Tool Based on Payer, Provider, and Patient Priorities: Findings From the 2021 Care Pathways Working Group
05/20/2022
Winston Wong, PharmD
Gordon Kuntz
Robin T Zon, MD, FACP, FASCO
2021 Care Pathways Working Group
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways convened the 2021 Care Pathways Working Group to identify and reconcile the different pathway drivers for each stakeholder now and five years into the future, creating a framework tool based on oncology care...
The Journal of Clinical Pathways...
05/20/2022
Journal of Clinical Pathways

Advertisement

Advertisement

Advertisement

Advertisement

Subscribe

Journal of Clinical Pathways Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement